SCHEMBL5156572

SCHEMBL5156572

O=C(O)CCn1c2ccccc2c2ccc(OCCCCOc3cccc4c3CCCC4=O)cc21

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 1/20 0.46
PSEN1 P49768 7/20 0.45
PSEN2 P49810 7/20 0.45
APH1B Q8WW43 7/20 0.45
NCSTN Q92542 7/20 0.45
APH1A Q96BI3 7/20 0.45
PSENEN Q9NZ42 7/20 0.45
FABP4 P15090 3/20 0.44
FABP5 Q01469 3/20 0.44
FABP3 P05413 1/20 0.44
KDM4E B2RXH2 2/20 0.44
ALDH1A1 P00352 1/20 0.44
LTB4R Q15722 3/20 0.43
LTB4R2 Q9NPC1 3/20 0.43
HPGD P15428 1/20 0.43
MCL1 Q07820 2/20 0.41
PLA2G2A P14555 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5152540 0.95 PSEN1 (0.46) MRGPRX4PSEN1PSEN2APH1BNCSTN
SCHEMBL5151311 0.90 MRGPRX4 (0.47) MRGPRX4PSEN1PSEN2APH1BNCSTN
SCHEMBL5149581 0.89 MRGPRX4 (0.46) MRGPRX4PSEN1PSEN2APH1BNCSTN
SCHEMBL5315833 0.87 MRGPRX4 (0.40) MRGPRX4PSEN1PSEN2APH1BNCSTN
SCHEMBL5152291 0.85 MAOB (0.54) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5156096 0.85 PSEN1 (0.45) MRGPRX4PSEN1PSEN2APH1BNCSTN
SCHEMBL5151495 0.84 PPARG (0.44) MRGPRX4PSEN1PSEN2APH1BNCSTN
SCHEMBL5152180 0.82 PSEN1 (0.46) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5151921 0.82 PSEN1 (0.49) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5151952 0.82 PSEN1 (0.52) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070197524-A1 Fluorenes and carbazoles as ligands of the EP2 receptor BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-08-23 US claimed
WO-2007071456-A1 FLUORENES AND CARBAZOLES AS LIGANDS OF THE EP2 RECEPTOR BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-06-28 WO claimed
US-20070197524-A1 Fluorenes and carbazoles as ligands of the EP2 receptor BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-08-23 US disclosed
US-20070197524-A1 Fluorenes and carbazoles as ligands of the EP2 receptor BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-08-23 US disclosed
US-20070197524-A1 Fluorenes and carbazoles as ligands of the EP2 receptor BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197524-A1 Fluorenes and carbazoles as ligands of the EP2 receptor PTGER2, PTGER1, PTGDR2 MRGPRX4 243/4885PSEN1 2971/4885PSEN2 1240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.